Markets
Negative
Stoke Therapeutics Names Ian Smith As CEO; Phase 3 Trial Of Zorevunersen Underway
Breaking news from global financial markets
1 month ago
Read More
1 month ago
1,592
1 month ago
4,355
1 month ago
2,260
1 month ago
3,113
1 month ago
1,804
1 month ago
2,258
1 month ago
875
Kaltura finance chief steps down
Ratings
1 month ago
2,516
1 month ago
2,872
1 month ago
3,007
1 month ago
3,862
1 month ago
2,834
Dragonfly Energy Announces Pricing of $25.0 Million Underwritten Offering of Common Stock
Technology
1 month ago
1,041
1 month ago
2,338
Trending Now
1
Alliance Creative Group (ACGX) Releases 2025 Q3 Quarterly Financial and Disclosu...
42,697
29 minutes ago
2
Dillard’s, Inc. Reports Third Quarter and Year-to-Date Results
6,593
31 minutes ago
3
Critical One Energy Appoints Chief Geological Officer to Advance Flagship Antimo...
38,559
31 minutes ago
4
RentRedi Launches “Late Rent Report” to Help Landlords Track and Collect Rent Fa...
27,692
31 minutes ago
5
MarineMax GAAP EPS of -$0.04 beats by $0.19, revenue of $552.2M beats by $19.15M
41,377
34 minutes ago